guillain barre syndrome and glutathione Guillain‐Barré syndrome: a comprehensive review Biological Drugs in Guillain-Barré Syndrome:

Poly(lactic co-glycolic acid) nanoparticles have been used for delivering catalase to human neuronal cells, and the protection by these catalase-loaded nanoparticles against oxidative stress was evaluated [143]

A history of exposure to a hepatotoxicant and the presence of multiple nodules of regeneration that maintain a lobular but usually distorted architecture makes diagnosis more convincing

Multi-omics integration was conducted to reveal core regulatory networks, and mechanistic validation focused on the expression of Nrf2, HO-1, and GPX4

One study demonstrated that GSH levels in the hippocampus and cortex are significantly reduced in patients with mild cognitive impairment (MCI) and AD

Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems